in vitro treatment of parental c57bl/6 lymphohematopoietic cell grafts with unabsorbed guinea pig anti-mouse thymocyte serum ( ats ) and guinea pig complement ( gpc ) , prior to inoculation into lethally irradiated b6d2f hybrid hosts , has proven to be of value in terms of mitigating graft-versus-host disease ( gvhd ) .
C0229671
serum
C0009498
complement